Naji, Duraid Hamid
Tan, Chengcheng
Han, Fabin
Zhao, Yuanyuan
Wang, Junhan
Wang, Dan
Fa, Jingjing
Li, Sisi
Chen, Shanshan
Chen, Qiuyun
Xu, Chengqi
Wang, Qing K.
Funding for this research was provided by:
China National Natural Science Foundation ((2011ZX09307-001-09))
Article History
Received: 15 July 2017
Accepted: 29 August 2017
First Online: 11 September 2017
Compliance with ethical standards
:
: This study was supported by the China National Natural Science Foundation Grants (31430047, 81630002 and 31671302), Chinese National Basic Research Programs (973 Programs 2013CB531101 and 2012CB517801), Hubei Province’s Outstanding Medical Academic Leader Program, Hubei Province Natural Science Program (2014CFA074 and 2016CFB224), the China National Natural Science Foundation Grant (91439129, NSFC-J1103514), NIH/NHLBI Grants R01 HL121358 and R01 HL126729, Specialized Research Fund for the Doctoral Program of Higher Education from the Ministry of Education, and the “Innovative Development of New Drugs” Key Scientific Project (2011ZX09307-001-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
: All authors have no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of College of Life Science and Technology, Huazhong University of Science and Technology and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.